Clinical Trial Update: A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reports termination of a study evaluating the effect of ustekinumab on cytochrome P450 enzyme activities in adults with active Cro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn Disease, Ulcerative Colitis | Phase 1 | Status: TERMINATED